Moreover, meta-analyses show that stem cells derived from bone marrow are more effective than those derived from the umbilical cord, and superior improvement in model for end-stage liver disease (MELD) score, albumin (ALB) levels, alanine aminotransferase (ALT) levels, and total bilirubin (TBil) occurred in the bone marrow mesenchymal stem cell (BMMSC) group than umbilical cord mesenchymal stem cell (UCMSC) group [8]. This evidence concerns the gene GPT and End Stage Liver Disease.